Literature DB >> 8749961

Multicenter study of creatine kinase-MB use: effect on chest pain clinical decision making.

J R Hedges1, W B Gibler, G P Young, J W Hoekstra, C Slovis, R Aghababian, M Smith, M Rubison.   

Abstract

OBJECTIVE: To determine whether creatine kinase-MB isomer (CK-MB) levels affect initial physician decisions regarding patients with potential cardiac chest pain.
METHODS: A prospective, multicenter, observational cohort study was performed at seven university teaching hospital EDs. Hemodynamically stable chest pain patients > or = 25 years old and without ST-segment elevation on their ECGs were observed with one to two sets of CK-MB level determinations obtained three hours apart prior to disposition. The physicians committed to a dichotomous (yes/no) absolute decision regarding the diagnosis of myocardial infarction (MI), need for hospital admission, and need for coronary care unit (CCU) admission both before and after enzyme results were obtained. The physicians ranked the perceived importance of initial history and physical, serial clinical observation, initial ECG, and CK-MB level to their decision making (rank score: 1 = most important, 4 = least important).
RESULTS: Of the 1,042 patients enrolled, 777 (74.6%) were admitted to the hospital. For the 67 MI patients (8.6% of the admissions), changes in absolute decisions about the diagnosis of MI and planned CCU admission were associated with increased CK-MB importance (p = 0.04 and p = 0.02, respectively). Of the 146 patients who had new-onset angina or unstable angina, changes in absolute decisions were not associated with CK-MB importance. No patient who had MI or unstable angina was released from the ED. There were three of 67 (4%) MI patients and one of 146 (1%) unstable/new-onset angina patients initially slated for release home who were admitted to the hospital.
CONCLUSIONS: For a minority of the patients who had subsequently proven MI, the CK-MB result helped guide disposition decisions. The CK-MB availability did not adversely impact the disposition of the patients who had unstable or new-onset angina.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8749961     DOI: 10.1111/j.1553-2712.1996.tb03295.x

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  4 in total

1.  Early diagnosis of myocardial infarction: why measure cardiac enzymes?

Authors:  P O Collinson
Journal:  J Clin Pathol       Date:  1998-01       Impact factor: 3.411

Review 2.  Accident and emergency medicine.

Authors:  S A Stahmer
Journal:  BMJ       Date:  1998-04-04

3.  Safe discharge from the cardiac emergency room with a rapid rule-out myocardial infarction protocol using serial CK-MB(mass).

Authors:  R Bholasingh; R J de Winter; J C Fischer; R W Koster; R J Peters; G T Sanders
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

Review 4.  Cardiovascular biomarkers in body fluids: progress and prospects in optical sensors.

Authors:  Reena V John; Tom Devasiya; Nidheesh V R; Sphurti Adigal; Jijo Lukose; V B Kartha; Santhosh Chidangil
Journal:  Biophys Rev       Date:  2022-08-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.